MINERALYS THERAPEUTICS, INC.

Profile

Company Names

MINERALYS THERAPEUTICS, INC.

Addresses

150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA 19087

Phone Numbers

(888) 378-6240

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$117,999,994.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-06-01 
$117,999,994.00 
$117,999,994.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SRINIVAS 
 
AKKARAJU 
DIRECTOR
SEATTLE GENETICS INC /WA   |  PRESIDIO PHARMACEUTICALS, INC.   |  VERSARTIS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  SYROS PHARMACEUTICALS, INC.   |  SAMSARA BIOCAPITAL, L.P.   |  565 SPV I, L.P.   |  TENTARIX BIOTHERAPEUTICS, LP   |  CHINOOK THERAPEUTICS U.S., INC.   |  MINERALYS THERAPEUTICS, INC.   |  ORSOBIO, INC.   |  VTV THERAPEUTICS INC.   |  ALUMIS INC.   |  SAMSARA OPPORTUNITY FUND, L.P.
ALEXANDER 
 
ASAM 
DIRECTOR
AUTONOMIC TECHNOLOGIES INC   |  ARCUTIS BIOTHERAPEUTICS, INC.   |  MINERALYS THERAPEUTICS, INC.
JON 
 
CONGLETON 
EXECUTIVE OFFICER, DIRECTOR
IMPEL NEUROPHARMA INC   |  MINERALYS THERAPEUTICS, INC.
DEREK 
 
DIROCCO 
DIRECTOR
WEREWOLF THERAPEUTICS, INC.   |  DAY ONE BIOPHARMACEUTICALS HOLDING CO LLC   |  ACRIVON THERAPEUTICS, INC.   |  MINERALYS THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.   |  EVOMMUNE, INC.   |  BAMBUSA THERAPEUTICS, INC.   |  STIPPLE BIO, INC.
ADAM 
 
LEVY 
EXECUTIVE OFFICER
NEXGEL, INC.   |  CRATE INC.   |  MINERALYS THERAPEUTICS, INC.   |  TIGER + BULLDOG OHIO FUND, LP
OLIVIER 
 
LITZKA 
DIRECTOR
JENAVALVE TECHNOLOGY INC   |  AUTONOMIC TECHNOLOGIES INC   |  MINERALYS THERAPEUTICS, INC.   |  MEDICAL MICROINSTRUMENTS, INC.
TAKESHI 
 
TAKAHASHI 
DIRECTOR
EXALYS THERAPEUTICS, INC.   |  MINERALYS THERAPEUTICS, INC.
BRIAN 
 
TAYLOR SLINGSBY 
DIRECTOR
MINERALYS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-06-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#